Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

FRESENIUS SE : JP Morgan reiterates its Buy rating

05/04/2021 | 07:41am EDT

In his latest research note, analyst David Adlington confirms his positive recommendation. The broker JP Morgan is keeping its Buy rating. The target price remains unchanged at EUR 50.


ę MarketScreener with dpa-AFX Analyser 2021
All news about FRESENIUS SE & CO. KGAA
05/10FRESENIUS SEá : Credit Suisse sticks Neutral
MD
05/10FRESENIUSá : Conference Call Q1 2021, Fresenius (PDF, 1.87 MB)
PU
05/10FRESENIUS MEDICAL CAREá : Credit Suisse Raises Price Target on Fresenius Medical..
MT
05/10FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse gives a Neutral rating
MD
05/07FRESENIUSá : Quarterly Financial Report (PDF)
PU
05/07FRESENIUSá : Quarterly Financial Report Q1 2021 (IFRS) (PDF, 0.60 MB)
PU
05/07FRESENIUSá : Statement of the Management on the countermotion (PDF, 90 KB)
PU
05/07FRESENIUS SEá : Deutsche Bank sticks Neutral
MD
05/07FMC FRESENIUS MEDICAL CARE AG & CO K : Deutsche Bank sticks Neutral
MD
05/07FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Berenberg
MD
More news
Financials
Sales 2021 36 829 M 44 716 M 44 716 M
Net income 2021 1 760 M 2 137 M 2 137 M
Net Debt 2021 22 855 M 27 749 M 27 749 M
P/E ratio 2021 13,5x
Yield 2021 1,96%
Capitalization 24 125 M 29 338 M 29 291 M
EV / Sales 2021 1,28x
EV / Sales 2022 1,17x
Nbr of Employees 311 269
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 46,90 €
Last Close Price 43,27 €
Spread / Highest target 84,9%
Spread / Average Target 8,38%
Spread / Lowest Target -59,2%
EPS Revisions
Managers and Directors
NameTitle
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Gerd Krick Chairman-Supervisory Board
Sebastian Biedenkopf Legal, Compliance & Human Resources Director
Klaus-Peter MŘller Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA14.35%28 233
AIER EYE HOSPITAL GROUP CO., LTD.-7.48%44 392
TOPCHOICE MEDICAL CORPORATION10.59%15 242
IHH HEALTHCARE2.91%12 083
RAMSAY HEALTH CARE LIMITED1.25%11 250
BANGKOK DUSIT MEDICAL SERVICES0.00%11 093